Automated description from the Alliance of Genome Resources
Predicted to have prostacyclin receptor activity. Involved in several processes, including negative regulation of platelet-derived growth factor receptor signaling pathway; negative regulation of smooth muscle cell proliferation; and response to lipopolysaccharide. Predicted to localize to the cytosol and plasma membrane. Orthologous to human PTGIR (prostaglandin I2 receptor).